Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LifeStance Health Group, Inc.LFST · Entity 3936 | See Remarks | May 10, 2024 | May 14, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LifeStance Health Group, Inc.
Report date May 10, 2024 · Filed May 14, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 239,915 |
Ending reported balance
After 2024-05-13 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2024-05-10 · Sale · Disposed 2,000 · Balance 288,193 F1: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.00 to $7.01 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Row 2 · 2024-05-13 · Sale · Disposed 48,278 · Balance 239,915 F2: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.01 to $7.50 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.00 to $7.01 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F2: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.01 to $7.50 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 13, 2024 Filed May 14, 2024 20:30 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | SaleCommon Stock | 48,278 | $7.22 | $348,567.16 |
DisclosureSEC source: 0000950170-24-059636 · ownership.xml · nonDerivative · entry 2 Cipollone Paula · CIK 0001993631 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 239,915 F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.01 to $7.50 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| May 10, 2024 Filed May 14, 2024 20:30 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | SaleCommon Stock | 2,000 | $7.00 | $14,000.00 |
DisclosureSEC source: 0000950170-24-059636 · ownership.xml · nonDerivative · entry 1 Cipollone Paula · CIK 0001993631 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 288,193 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.00 to $7.01 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 01:50 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | SaleCommon Stock | 13,996 | $6.93 | $96,992.28 |
DisclosureSEC source: 0000950170-24-030462 · ownership.xml · nonDerivative · entry 3 Cipollone Paula · CIK 0001993631 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 293,562 F3 · kind: Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| March 08, 2024 Filed Mar 13, 2024 01:50 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | GrantCommon Stock | 32,052 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-030462 · ownership.xml · nonDerivative · entry 2 Cipollone Paula · CIK 0001993631 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 307,558 F2 · shares: Represents performance-based restricted stock units previously granted to the Reporting Person, which vested on March 8, 2024. Read SEC document |
| March 08, 2024 Filed Mar 13, 2024 01:50 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | GrantCommon Stock | 62,413 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-030462 · ownership.xml · nonDerivative · entry 1 Cipollone Paula · CIK 0001993631 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 275,506 F1 · shares: Includes 62,413 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| January 03, 2024 Filed Apr 11, 2024 20:30 UTC | LifeStance Health Group, Inc. LFST · Entity 3936 | SaleCommon Stock | 3,369 | $7.45 | $25,099.05 |
DisclosureSEC source: 0000950170-24-043728 · ownership.xml · nonDerivative · entry 1 Cipollone Paula · CIK 0001993631 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 290,193 F1 · kind: Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · balance_after: Represents the amount of securities beneficially owned by the Reporting Person as of the date this Report was filed. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.